Looking for volunteers
Impact of Augmented Reality During Robot-assisted Radical Prostatectomy
NCT06059859 · European Institute of Oncology · Updated 12 Aug 2025
- What is being tested
- Augmented reality robot-assited radical prostatectomy; Mixed reality intraoperative frozen section analysis; Robot-assited radical prostatectomy
- For
- Prostatic Neoplasm
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 70 years. About 318 people. The full rules are on the registry page.
- Where
- Italy
- When
- Starts or started 1 Jan 2022, ends 1 Jan 2026. Registered 29 Sept 2023.
- Results
- None posted yet.
In the researchers' words
Accurate preservation of neuro-vascular bundles is crucial in guaranteeing erectile function recovery after robot assisted radical prostatectomy (RARP). However, the nerve sparing approach is associated with higher rates of positive surgical margins (PSM) at final pathology. Augmented reality (AR) RARP was previously associated with a 10-15% reduction in the rates of PSMs in two retrospective series. However, prospective studies are needed to demonstrate clinical utility and to validate these technologies. The hypotheses of this study are that: 1) AR RARP reduces the rates of PSMs, if compared to standard approach; 2) AR RARP can guarantee a more accurate preservation of neurovascular bundles and, in consequence, a greater recovery of erectile function; 3) the lower rates of PSMs will translate in greater oncological control of the disease.
Sites
- European Institute of OncologyMilan, Italy